What is HNGE's last price and market cap on Chartloom?

The overview shows a last price near n/a and market cap near 8.47B (subject to data latency), alongside the price snapshot and profile on this page.

What P/E and 52-week range are shown for HNGE?

P/E (TTM) is 77.79 and 52-week range is $30.08 to $107.00 when available from the data feed; see the metrics and chart on this page.

Where do Chartloom’s HNGE figures come from?

Figures are compiled from market data and SEC-backed fundamentals used in the app. Use primary filings and a broker for trading decisions.

What trailing-twelve-month financials does Chartloom show for HNGE?

The company profile lists revenue (TTM) near $668M, net income (TTM) near $101M, EPS (TTM) near $1.33 when available from the market-data feed. Figures are informational and may lag live markets.

Where is Hinge Health Inc based, and what identifiers does Chartloom list?

The company context section lists headquarters in San Francisco, California, US, 77.4M shares outstanding, ISIN US4333131039 when available from company profile and filing metadata.

Please enable JavaScript to continue using this application.

Hinge Health Inc

$HNGE

Health Care · Health Care Providers & Services

Run Scenarios

$105.00

-0.13%

Overview AI Summary Charts Financials Valuation

Profile

Read AI summary

Hinge Health, Inc. is a digital healthcare company, which engages in software for joint and muscle health care. The company is headquartered in San Francisco, California and currently employs 1,437 full-time employees. The company went IPO on 2025-05-22. The firm has designed its TrueMotion platform to address a spectrum of musculoskeletal (MSK) care from acute injury to chronic pain, to post-surgical rehabilitation. Members receive personalized and automated MSK care through its AI-powered motion tracking technology. The company offers electrical nerve stimulation wearable device Enso, all designed and monitored by its AI-supported care team of licensed physical therapists, physicians, and board-certified health coaches. Its platform offers a range of support with multiple programs across many affected areas to provide a continuum of care from prevention to treatment of acute injury and chronic pain, as well as surgery decision support and post-surgical recovery. Enso delivers electrical nerve stimulation designed to provide non-addictive and non-invasive pain relief.

Employees

1,437

Website

en-gb.hingehealth.com/

IPO

2025-05-22

Beta

Next earnings date

—

Financials & valuation

Open valuation

Revenue (TTM)